269 related articles for article (PubMed ID: 35143332)
1. Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases.
Barrera-Chimal J; Bonnard B; Jaisser F
Annu Rev Physiol; 2022 Feb; 84():585-610. PubMed ID: 35143332
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effects of mineralocorticoid receptor antagonists.
van den Berg TN; Rongen GA; Fröhlich GM; Deinum J; Hausenloy DJ; Riksen NP
Pharmacol Ther; 2014 Apr; 142(1):72-87. PubMed ID: 24275323
[TBL] [Abstract][Full Text] [Related]
3. Role of mineralocorticoid receptor antagonists in cardiovascular disease.
Ferrario CM; Schiffrin EL
Circ Res; 2015 Jan; 116(1):206-13. PubMed ID: 25552697
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid Receptor and Cardiovascular Disease.
Buonafine M; Bonnard B; Jaisser F
Am J Hypertens; 2018 Oct; 31(11):1165-1174. PubMed ID: 30192914
[TBL] [Abstract][Full Text] [Related]
5. Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
Kolkhof P; Jaisser F; Kim SY; Filippatos G; Nowack C; Pitt B
Handb Exp Pharmacol; 2017; 243():271-305. PubMed ID: 27830348
[TBL] [Abstract][Full Text] [Related]
6. Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology.
Jaisser F; Farman N
Pharmacol Rev; 2016 Jan; 68(1):49-75. PubMed ID: 26668301
[TBL] [Abstract][Full Text] [Related]
7. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.
Davel AP; Jaffe IZ; Tostes RC; Jaisser F; Belin de Chantemèle EJ
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H989-H999. PubMed ID: 29957022
[TBL] [Abstract][Full Text] [Related]
8. The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature.
Belden Z; Deiuliis JA; Dobre M; Rajagopalan S
Am J Nephrol; 2017; 46(4):298-314. PubMed ID: 29017166
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders - New perspectives for combination therapy.
Kolkhof P; Joseph A; Kintscher U
Pharmacol Res; 2021 Oct; 172():105859. PubMed ID: 34461222
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor and cardiac arrhythmia.
Gravez B; Tarjus A; Jaisser F
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):910-5. PubMed ID: 23888997
[TBL] [Abstract][Full Text] [Related]
11. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
Chrissobolis S
Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoids in the heart and vasculature: new insights for old hormones.
Lother A; Moser M; Bode C; Feldman RD; Hein L
Annu Rev Pharmacol Toxicol; 2015; 55():289-312. PubMed ID: 25251996
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
Dinh QN; Young MJ; Evans MA; Drummond GR; Sobey CG; Chrissobolis S
Brain Res; 2016 Apr; 1637():146-153. PubMed ID: 26923165
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction.
Igbekele AE; Jia G; Hill MA; Sowers JR; Jia G
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012219
[TBL] [Abstract][Full Text] [Related]
15. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention.
Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W
Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
Galuppo P; Bauersachs J
Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists.
Sueta D; Yamamoto E; Tsujita K
Curr Hypertens Rep; 2020 Feb; 22(3):21. PubMed ID: 32114686
[TBL] [Abstract][Full Text] [Related]
18. Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor.
Clarisse D; Deng L; de Bosscher K; Lother A
Br J Pharmacol; 2022 Jul; 179(13):3235-3249. PubMed ID: 34698367
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries.
Sztechman D; Czarzasta K; Cudnoch-Jedrzejewska A; Szczepanska-Sadowska E; Zera T
J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30898981
[TBL] [Abstract][Full Text] [Related]
20. Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
Parviz Y; Iqbal J; Pitt B; Adlam D; Al-Mohammad A; Zannad F
Trends Endocrinol Metab; 2015 Apr; 26(4):201-11. PubMed ID: 25707577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
